Read + Share
Amedeo Smart
Independent Medical Education
Li S, Wu J, Huang O, He J, et al. Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients. BMC Cancer 2021;21:807.PMID: 34256710
Email
LinkedIn
Facebook
Twitter
Privacy Policy